R

Recbio

18 employees

Focusing on major innovative vaccines with independent intellectual property rights.

Basic info

Industry

biotechnology research

Sectors

Health Care
COVID19 Vaccine
Adjuvant
Vaccine
HPV Vaccine
Life Science

Date founded

2012

Funding rounds raised

Total raised

$227M

from 15 investors over 15 rounds

R

Recbio raised $156M on June 14, 2021

Investors: LYFE Capital, Lake Bleu Capital (Hong Kong) Limited, E Fund Management Co.,LTD., Temasek, Legend Capital, Boyu Capital and Sequoia Capital China

R

Recbio raised $227M on November 11, 2020

Investors: LYFE Capital, 祥恩股权投资管理(上海)有限公司, 中国光大投资管理有限责任公司, Legend Capital, Sequoia Capital China and 青松基金

R

Recbio raised $71M on November 1, 2019

Investors: 东方富海 and CMB International

FAQ